The Music4Diabetes Consortium launched a new project to improve Type 1 Diabetes treatment.
We are proud to be one of the seven consortium members, benefitting from a €3.8m European Innovation Council grant.
The new website is live: https://t.co/UEteyb2ayl
Our CEO, Danaë Delbeke , presented at #LSIEurope23 where she showcased the potential of our Continuous Multi-metabolite Monitoring (#CMM™)
Find out about this disruptive technology on our website or contact [email protected] to request a meeting.
#LSIEurope#diabetes
Indigo is growing! Over the last 2 years our team has tripled in size and we currently have 10 open positions. Find out more here: https://t.co/TuusOIkZAn
#recruitment#hiring
Dear DogeGF community, we listened to your suggestions so we invite you to be a part of our first burn announcement here on Twitter! 🔥
Each retweet burns 100$ worth of DogeGF, max amount for this burn is 500k $.
You have 24 hrs to retweet this message until we burn the tokens.
Looking forward to hosting a virtual booth at the 12th International Conference on ATTD on 2- 5 June. To secure your spot, register here: https://t.co/bF3zNgEQ4V
#ATTD2021#CMM#CGM
Great to be featured in @Medtech Insight’s review of the emerging technologies that aim to replace current blood glucose monitoring. Read more about it in an insightful interview with our new Chairman, @Paul Moraviec here:
https://t.co/j0ykCvS3kn
We are pleased to announce that @Paul Moraviec has joined Indigo as Chairman of our Board. Paul brings decades of leadership experience in the Global MedTech sector and we are looking forward to welcoming him to the @Indigo team. #diabetes#medtech#leadership
Our CEO and co-founder Danaë Delbeke was one of 35 CEOs of high growth companies who met yesterday to discuss how to improve #innovation in Europe. Thank you @GabrielMariya for inviting us.
Read more from here: https://t.co/bzRXj425EF
Good news. The first three participants in our clinical trial have been implanted with their continuous multi-metabolite (#CMM) sensor, which has been designed to give live measurements of glucose, ketone and lactate in people living with #diabetes. https://t.co/ELRlOiOZAF
"We are happy to announce that we have raised 38 million euro to further develop and test our multi-biomarker sensor for people with diabetes. The video below shows how we hope to change the life of people with diabetes all over the world” #Diabetes#CGM#QualityOfLife